Abstract:Candidate tumour suppressor ZMYND11 specifically recognizes histone K36 trimethylation on the histone variant H3.3 and helps regulate transcription elongation. This study identifies the PHD–bromo–PWWP cassette of the candidate tumour suppressor ZMYND11 as a specific 'reader' of trimethylated K36 on the histone variant H3.3. ZMYND11 seems to accumulate on gene bodies during transcription and functions in modulating transcription elongation. Structural and genomics experiments reveal the chromatin-binding properties of ZMYND11, and it is shown to be important for repressing transcription of genes linked to tumour cell growth. Recognition of modified histones by ‘reader’ proteins plays a critical role in the regulation of chromatin1. H3K36 trimethylation (H3K36me3) is deposited onto the nucleosomes in the transcribed regions after RNA polymerase II elongation. In yeast, this mark in turn recruits epigenetic regulators to reset the chromatin to a relatively repressive state, thus suppressing cryptic transcription2. However, much less is known about the role of H3K36me3 in transcription regulation in mammals. This is further complicated by the transcription-coupled incorporation of the histone variant H3.3 in gene bodies3. Here we show that the candidate tumour suppressor ZMYND11 specifically recognizes H3K36me3 on H3.3 (H3.3K36me3) and regulates RNA polymerase II elongation. Structural studies show that in addition to the trimethyl-lysine binding by an aromatic cage within the PWWP domain, the H3.3-dependent recognition is mediated by the encapsulation of the H3.3-specific ‘Ser 31’ residue in a composite pocket formed by the tandem bromo–PWWP domains of ZMYND11. Chromatin immunoprecipitation followed by sequencing shows a genome-wide co-localization of ZMYND11 with H3K36me3 and H3.3 in gene bodies, and its occupancy requires the pre-deposition of H3.3K36me3. Although ZMYND11 is associated with highly expressed genes, it functions as an unconventional transcription co-repressor by modulating RNA polymerase II at the elongation stage. ZMYND11 is critical for the repression of a transcriptional program that is essential for tumour cell growth; low expression levels of ZMYND11 in breast cancer patients correlate with worse prognosis. Consistently, overexpression of ZMYND11 suppresses cancer cell growth in vitro and tumour formation in mice. Together, this study identifies ZMYND11 as an H3.3-specific reader of H3K36me3 that links the histone-variant-mediated transcription elongation control to tumour suppression.

SMYD5 Catalyzes Histone H3 Lysine 36 Trimethylation at Promoters

Histone H3 Lysine 4 Monomethylation Modulates Long-Range Chromatin Interactions at Enhancers

SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation.

Identification of H3K4me1-associated Proteins at Mammalian Enhancers

Histone Methyltransferase SMYD2: Ubiquitous Regulator of Disease

Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3

Functional Analysis of the Methyltransferase SMYD in the Single-Cell Model Organism Tetrahymena Thermophila

Histone methyltransferase SMYD3 and tumor

SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma

SMYD5 is a ribosomal methyltransferase which trimethylates RPL40 lysine 22 through recognition of a KXY motif

Regulation of EZH2 by SMYD2-Mediated Lysine Methylation is Implicated in Tumorigenesis.

SMYD3 Associates with the NuRD (MTA1/2) Complex to Regulate Transcription and Promote Proliferation and Invasiveness in Hepatocellular Carcinoma Cells

Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation

N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2

Histone Lysine Methyltransferase SMYD3 Promotes Oral Squamous Cell Carcinoma Tumorigenesis Via H3K4me3-mediated HMGA2 Transcription

SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression

ZMYND11 Links Histone H3.3K36me3 to Transcription Elongation and Tumour Suppression.

Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase*

H3K36 Methylation - a Guardian of Epigenome Integrity

Effects of SMYD3 Overexpression on Transformation, Serum Dependence, and Apoptosis Sensitivity in NIH3T3 Cells

Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells